Recent news on Activase

Full Text  -  25 May 2007
Science Magazine (subscription)...cleavage of the 5'-C–S bond of S-adenosyl-L-methionine by a separate activase protein (class III), as the ultimate oxidant for cysteine activation.

Zolpidem Tartrate Syrup (Zolpidem Tartrate capsule) Information  -  May 19, 2007
American Chronicle,Zolpidem Tartrate helps in the mechanism is unknown but may involve subunit modulation of the aminobutyrate activase (GABA) receptor chloride channel

Denenberg: Emphasizing The Difference Between Male And Female ...  -  Mar 29, 2007
Evening Bulletin,Such strokes can be treated by tissue plasminogen activator (tPA, Activase). That drug busts clots and restores blood flow to the brain.

No go for Novo's potential stroke therapy  -  Feb 28, 2007
DrugResearcher.com,Currently, the only approved treatment for ischaemic strokes is Genentech's Activase. Another recombinant protein-based drug, the drug activates plasminogen

ASA: Intracranial Thrombolytics Prompt Dramatic Stroke Response  -  Feb 12, 2007
MedPage Today,12 -- A quarter of stroke patients given the thrombolytic Activase (tPA, Alteplase) in a six-hour intra-arterial window, twice the FDA-approved intravenous

ASA: tPA Increasingly Common for Childhood Stroke  -  Feb 8, 2007
MedPage Today,8 -- Activase (alteplase, tPA), the thrombolytic tissue plasminogen activator, is increasingly being used for childhood ischemic stroke even though it has

Clot-buster drug safe for treating stroke: study  -  Jan 27, 2007
The Brunei Times,The drug, alteplase, is produced by the California-based biotechnology company Genentech under the brand name Activase. Scientists who tested it on stroke

ASA: Stroke Symptoms in Women Often Atypical  -  Feb 8, 2007
MedPage Today,...she is less likely to fast track women to brain imaging, which risks missing the critical window for treatment with the thrombolytic Activase (tPA,

Genentech Earnings Surge  -  Jan 10, 2007
Wall Street Journal (subscription),After first coaxing living cells to churn out human insulin and human growth hormone, it came up with the clot buster Activase for heart attacks.

VaxGen Restructures to Reduce Spending and Retains Lazard to ...  -  Jan 5, 2007
PharmaLive.com (press release),...(Nutropin(R) and Protropin(R)), heart attack (Activase(R) and TNKase(TM)), non-Hodgkin's lymphoma (Rituxan(R)) and breast cancer (Herceptin(R)).

VaxGen Restructures to Reduce Spending and Retains Lazard to ...  -  Jan 5, 2007
Yahoo! News (press release)...deficiency (Nutropin® and Protropin®), heart attack (Activase® and TNKase(TM)), non-Hodgkin's lymphoma (Rituxan®) and breast cancer (Herceptin®).

Wife Sues Hospital Over Husband's Stroke Treatment  -  Nov 29, 2006
WBAL Channel.com,Michelle said a year after her husband's death, she learned about activase -- a clot- busting drug that if given within three hours of a stroke can

Investors Dump Nuvelo On Alfimeprase's Phase III Data  -  Dec 11, 2006
BioWorld Online,...the first dose and to 80 percent of occluded catheters two hours after the second dose, compared with 46 percent and 62 percent with Cathflo Activase.

Three strikes for Bayer as alfimeprase trials fail  -  Dec 13, 2006
DrugResearcher.com,Drugs already on the market, such as Genentech's Activase (alteplase) activate the plasminogen system to degrade clots. Large clots, such as those found

Bayer hit by fresh pipeline failure with clotbuster  -  Dec 12, 2006
Pharma Times (subscription),Its thrombolytic product Cathflo Activase (alteplase) is the only product approved for clearing catheter blockages, and it had been expected that

Not All Hospitals Equipped To Handle Stroke Victims  -  Nov 27, 2006
WBAL Channel.com,A year later, Michelle Greer found out about Activase, or tPA, a drug that's been used since 1996 to break up blood clots in the brain.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional